US 11001592
DNA polymerase IIIC inhibitors and use thereof
granted A61KA61K31/519A61P
Quick answer
US patent 11001592 (DNA polymerase IIIC inhibitors and use thereof) held by Acurx Pharmaceuticals, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acurx Pharmaceuticals, Inc.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/519, A61P, A61P31/04